Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $407000.0.

  • Gossamer Bio's Other Non-Current Assets rose 4381.63% to $407000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $407000.0, marking a year-over-year increase of 4381.63%. This contributed to the annual value of $283000.0 for FY2024, which is 5420.71% down from last year.
  • According to the latest figures from Q3 2025, Gossamer Bio's Other Non-Current Assets is $407000.0, which was up 4381.63% from $383000.0 recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Other Non-Current Assets peaked at $1.3 million during Q2 2022, and registered a low of $59000.0 during Q2 2024.
  • For the 4-year period, Gossamer Bio's Other Non-Current Assets averaged around $580000.0, with its median value being $618000.0 (2023).
  • As far as peak fluctuations go, Gossamer Bio's Other Non-Current Assets crashed by 9233.77% in 2024, and later surged by 54915.25% in 2025.
  • Gossamer Bio's Other Non-Current Assets (Quarter) stood at $680000.0 in 2022, then fell by 9.12% to $618000.0 in 2023, then plummeted by 54.21% to $283000.0 in 2024, then soared by 43.82% to $407000.0 in 2025.
  • Its Other Non-Current Assets was $407000.0 in Q3 2025, compared to $383000.0 in Q2 2025 and $310000.0 in Q1 2025.